share_log

Returns On Capital At Intuitive Surgical (NASDAQ:ISRG) Paint A Concerning Picture

Returns On Capital At Intuitive Surgical (NASDAQ:ISRG) Paint A Concerning Picture

直觉外科公司(纳斯达克股票代码:ISRG)的资本回报率呈现出令人担忧的画面
Simply Wall St ·  09/15 10:22

There are a few key trends to look for if we want to identify the next multi-bagger. In a perfect world, we'd like to see a company investing more capital into its business and ideally the returns earned from that capital are also increasing. Ultimately, this demonstrates that it's a business that is reinvesting profits at increasing rates of return. However, after briefly looking over the numbers, we don't think Intuitive Surgical (NASDAQ:ISRG) has the makings of a multi-bagger going forward, but let's have a look at why that may be.

如果我们想要找到下一个百倍股,有几个关键趋势值得关注。在一个完美的世界里,我们希望看到一个公司将更多资本投入到业务中,并且最好从这些资本投资中获得的回报也在增加。这最终表明这是一个以递增的回报率重新投资利润的企业。然而,简要查看了这些数字后,我们认为直觉外科公司(纳斯达克股票代码:ISRG)将来可能不具备百倍股的特质,但我们可以看一看可能的原因。

Return On Capital Employed (ROCE): What Is It?

资本雇用回报率(ROCE)是什么?

Just to clarify if you're unsure, ROCE is a metric for evaluating how much pre-tax income (in percentage terms) a company earns on the capital invested in its business. The formula for this calculation on Intuitive Surgical is:

只是为了澄清,如果您不确定,ROCE是一个评估公司在其业务中投资的资本上赚取的税前收入百分比的指标。针对直觉外科公司的计算公式是:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

资产雇用回报率(ROCE)是指企业利润,即企业税前利润除以企业投入的总资本(负债加股权)。如果ROCE高于企业财务成本的承受能力,那么企业就会创造出更多的价值。

0.13 = US$2.0b ÷ (US$17b - US$1.5b) (Based on the trailing twelve months to June 2024).

0.13 = 20亿美元 ÷(170亿美元 - 15亿美元)(基于截至2024年6月的过去十二个月)。

So, Intuitive Surgical has an ROCE of 13%. In absolute terms, that's a satisfactory return, but compared to the Medical Equipment industry average of 9.6% it's much better.

因此,直觉外科公司的ROCE为13%。从绝对值上说,这是一个令人满意的回报,但与医疗设备行业的平均回报率9.6%相比,要好得多。

big
NasdaqGS:ISRG Return on Capital Employed September 15th 2024
纳斯达克股票代码:ISRG 回报资本雇用率 2024年9月15日

In the above chart we have measured Intuitive Surgical's prior ROCE against its prior performance, but the future is arguably more important. If you're interested, you can view the analysts predictions in our free analyst report for Intuitive Surgical .

在上面的图表中,我们对直觉外科公司之前的ROCE进行了衡量,但未来可能更重要。如果您有兴趣,可以在我们为直觉外科公司编制的免费分析师报告中查看分析师的预测。

The Trend Of ROCE

当寻找下一个倍增器时,如果您不确定从哪里开始,请关注几个关键趋势。首先,我们希望看到一个经过验证的资本使用率。如果您看到这一点,通常意味着这是一家拥有出色业务模式和大量盈利再投资机会的公司。然而,调查蒙托克可再生能源公司(NASDAQ:MNTK)后,我们认为它的现行趋势不符合倍增器的模式。

On the surface, the trend of ROCE at Intuitive Surgical doesn't inspire confidence. Around five years ago the returns on capital were 16%, but since then they've fallen to 13%. However, given capital employed and revenue have both increased it appears that the business is currently pursuing growth, at the consequence of short term returns. If these investments prove successful, this can bode very well for long term stock performance.

表面上看,直觉外科公司的ROCE趋势并不令人信心满满。大约五年前,资本回报率为16%,但此后下降到13%。然而,考虑到资本投入和营业收入均有增长,似乎业务目前正在追求增长,而短期回报则会受到影响。如果这些投资证明成功,那对于长期股票表现来说可能非常有利。

Our Take On Intuitive Surgical's ROCE

我们对直觉外科公司的ROCE的看法

While returns have fallen for Intuitive Surgical in recent times, we're encouraged to see that sales are growing and that the business is reinvesting in its operations. And the stock has done incredibly well with a 177% return over the last five years, so long term investors are no doubt ecstatic with that result. So while the underlying trends could already be accounted for by investors, we still think this stock is worth looking into further.

虽然直觉外科公司的回报率近年来有所下降,但我们看到销售额在增长,业务正在重投资其运营。而且,在过去的五年中,股票表现非常出色,回报率高达177%,因此长期投资者无疑对这个结果感到非常激动。因此,尽管潜在趋势已经被投资者考虑到,我们仍认为这支股票值得进一步研究。

On a final note, we've found 1 warning sign for Intuitive Surgical that we think you should be aware of.

最后,我们发现了一项预警信号,这对直觉外科公司的股票可能有影响,我们认为您应该了解这个情况。

While Intuitive Surgical isn't earning the highest return, check out this free list of companies that are earning high returns on equity with solid balance sheets.

虽然直觉外科公司的回报率不是最高的,但请查看这个免费的公司列表,这些公司在股东权益方面获得了高回报并拥有坚实的资产负债表。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发